baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

GSK PLC/ GB00BN7SWP63 /

10/18/2024 5:29:51 PM	Chg. -27.25	Volume	Bid-	Ask-	Market Capitalization	Dividend Y.	P/E Ratio
1,470.25GBX	-1.82%	839,078 Turnover(GBP): 12.39 mill.	-Bid Size: -	-Ask Size: -	59.34 bill.GBP	-	-

TeleTrader 10/10 GSK jumps 6% after Zantac settlements

Newsfile Corp 10/8 FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Newsfile Corp 10/7 Faruqi & Faruqi Reminds Moderna Investors of the Pending Class Action Lawsuit with a Lead Plaintiff ...

TeleTrader 10/4 Europe opens lower amid geopolitics, economic data

Newsfile Corp 10/1 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Newsfile Corp 9/30 SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Newsfile Corp 9/27 DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Newsfile Corp 9/24 DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Newsfile Corp 9/20 INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Mo...

Newsfile Corp 9/18 SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

TeleTrader 9/18 GSK settles two Zantac related cases

Newsfile Corp 9/16 ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

Newsfile Corp 9/16 Kalm Therapeutics Hires Former GSK Director Dr. Tomoko Maeda-Chubachi as Chief Medical Officer

Newsfile Corp 9/14 DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Moderna

GlobeNewswire 9/3 The 22nd China International Equipment Manufacturing Exposition held in Shenyang

GlobeNewswire 8/29 Anaptys Announces Participation in September Investor Conferences

GlobeNewswire 8/29 The International Myeloma Foundation (IMF) Brings Back ‘Do You #kNOwMyeloma?’ for Blood Cancer Aware...

GlobeNewswire 8/28 Korro Announces Addition of Industry Veteran Katharine Knobil to and Resignation of David Lucchino F...

GlobeNewswire 8/27 INVESTOR ALERT: Shareholder Class Action Lawsuit Filed Against Moderna, Inc. (NASDAQ: MRNA); Inves...

GlobeNewswire 8/27 SCYNEXIS to Participate in H. C. Wainwright 26th Annual Global Investment Conference

GlobeNewswire 8/26 First Patient Dosed with LIXTE’s LB-100 in New Clinical Trial to Treat Colorectal Cancer, Collaborat...

GlobeNewswire 8/20 Actuate Therapeutics to Ring the Nasdaq Opening Bell on Friday, August 23, 2024

GlobeNewswire 8/20 iTeos Therapeutics Announces Late-Breaking Oral Presentation of Phase 2 GALAXIES Lung-201 Interim Da...

GlobeNewswire 8/15 LIXTE Biotechnology Holdings to Present at Two Investor Conferences

GlobeNewswire 8/14 Actuate Therapeutics Announces Closing of Initial Public Offering

GSK PLC/ GB00BN7SWP63 /

If you wish to receive reply to your feedback, please provide your email address.